Nutrient regulates Tor1 nuclear localization and association with rDNA promoter H Li, CK Tsang, M Watkins, PG Bertram, XFS Zheng Nature 442 (7106), 1058-1061, 2006 | 280 | 2006 |
Low peak bone mass and attenuated anabolic response to parathyroid hormone in mice with an osteoblast-specific deletion of connexin43 DJ Chung, CHM Castro, M Watkins, JP Stains, MY Chung, VL Szejnfeld, ... Journal of cell science 119 (20), 4187-4198, 2006 | 189 | 2006 |
The conditional connexin43G138R mouse mutant represents a new model of hereditary oculodentodigital dysplasia in humans R Dobrowolski, P Sasse, JW Schrickel, M Watkins, JS Kim, M Rackauskas, ... Human molecular genetics 17 (4), 539-554, 2008 | 180 | 2008 |
Osteoblast connexin43 modulates skeletal architecture by regulating both arms of bone remodeling M Watkins, SK Grimston, JY Norris, B Guillotin, A Shaw, E Beniash, ... Molecular biology of the cell 22 (8), 1240-1251, 2011 | 170 | 2011 |
Bone turnover in bone biopsies of patients with low-energy cortical fractures receiving bisphosphonates: a case series R Armamento-Villareal, N Napoli, K Diemer, M Watkins, R Civitelli, ... Calcified tissue international 85, 37-44, 2009 | 148 | 2009 |
N-cadherin and cadherin 11 modulate postnatal bone growth and osteoblast differentiation by distinct mechanisms A Di Benedetto, M Watkins, S Grimston, V Salazar, C Donsante, ... Journal of cell science 123 (15), 2640-2648, 2010 | 138 | 2010 |
Connexin43 deficiency reduces the sensitivity of cortical bone to the effects of muscle paralysis SK Grimston, DB Goldberg, M Watkins, MD Brodt, MJ Silva, R Civitelli Journal of Bone and Mineral Research 26 (9), 2151-2160, 2011 | 89 | 2011 |
Enhanced periosteal and endocortical responses to axial tibial compression loading in conditional connexin43 deficient mice SK Grimston, MP Watkins, MD Brodt, MJ Silva, R Civitelli Public Library of Science 7 (9), e44222, 2012 | 78 | 2012 |
Molecular mechanisms of osteoblast/osteocyte regulation by connexin43 JP Stains, MP Watkins, SK Grimston, C Hebert, R Civitelli Calcified tissue international 94, 55-67, 2014 | 75 | 2014 |
p62 is required for stem cell/progenitor retention through inhibition of IKK/NF-κB/Ccl4 signaling at the bone marrow macrophage-osteoblast niche KH Chang, A Sengupta, RC Nayak, A Duran, SJ Lee, RG Pratt, ... Cell reports 9 (6), 2084-2097, 2014 | 69 | 2014 |
Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions VM Orellana-Noia, DR Reed, AA McCook, JM Sen, CM Barlow, ... Blood, The Journal of the American Society of Hematology 139 (3), 413-423, 2022 | 62 | 2022 |
Bisphosphonates improve trabecular bone mass and normalize cortical thickness in ovariectomized, osteoblast connexin43 deficient mice MP Watkins, JY Norris, SK Grimston, X Zhang, RJ Phipps, FH Ebetino, ... Bone 51 (4), 787-794, 2012 | 49 | 2012 |
Postnatal ablation of osteoblast Smad4 enhances proliferative responses to canonical Wnt signaling through interactions with β-catenin VS Salazar, N Zarkadis, L Huang, M Watkins, J Kading, S Bonar, J Norris, ... Journal of cell science 126 (24), 5598-5609, 2013 | 41 | 2013 |
Accentuated ovariectomy‐induced bone loss and altered osteogenesis in heterozygous N‐cadherin null mice CF Lai, SL Cheng, G Mbalaviele, C Donsante, M Watkins, GL Radice, ... Journal of Bone and Mineral Research 21 (12), 1897-1906, 2006 | 41 | 2006 |
CD19-targeted immunotherapies for treatment of patients with non-Hodgkin B-cell lymphomas MP Watkins, NL Bartlett Expert Opinion on Investigational Drugs 27 (7), 601-611, 2018 | 32 | 2018 |
Microfibril-associated glycoprotein-1, an extracellular matrix regulator of bone remodeling CS Craft, W Zou, M Watkins, S Grimston, MD Brodt, TJ Broekelmann, ... Journal of biological chemistry 285 (31), 23858-23867, 2010 | 31 | 2010 |
Connexin43 modulates post-natal cortical bone modeling and mechano-responsiveness SK Grimston, MP Watkins, JP Stains, R Civitelli BoneKEy reports 2, 2013 | 25 | 2013 |
N‐cadherin Regulation of Bone Growth and Homeostasis Is Osteolineage Stage–Specific F Fontana, CL Hickman‐Brecks, VS Salazar, L Revollo, G Abou‐Ezzi, ... Journal of Bone and Mineral Research 32 (6), 1332-1342, 2017 | 21 | 2017 |
Phase 1/dose expansion trial of brentuximab vedotin and lenalidomide in relapsed or refractory diffuse large B-cell lymphoma JP Ward, MM Berrien-Elliott, F Gomez, J Luo, M Becker-Hapak, ... Blood, The Journal of the American Society of Hematology 139 (13), 1999-2010, 2022 | 19 | 2022 |
An international analysis evaluating frontline bendamustine with rituximab in extranodal marginal zone lymphoma JP Alderuccio, L Arcaini, MP Watkins, AW Beaven, G Shouse, N Epperla, ... Blood advances 6 (7), 2035-2044, 2022 | 18 | 2022 |